So, who do we have out on the market to aim PR at the Beeb on the subject? Multiple Marketing with Sirco, and Healthspan with Circulease. Neither is known for general public awareness work, they are simply the first in the UK market. If the show had been in US, it is possible that the extra publicity from Langers would get Fruitflow a mention, albeit that their TV exposure was regional rather than national. The EU products dont register here either. So, still too early, although it seems so obvious to us with long term education, the media will still treat new claims with suspicion, even though we have unique EFSA and GRAS approval. That should count for loads of cred, but, at the moment, it still doesnt. We need those bigger promo budgets to bring about the big shift in awareness.
I have just watched the one show (I know sad ha ! ) but the doctor was saying how old people are dying in the cold weather , she mentioned higher blood pressure and, wait for it :::: sticky platelets !!!!!! no mention of fruitflow !!! and that's what I mean about visibility of a product , if there had been just one reference to a fruitflow product or mention of the effects fruitflow has on sticky platelets can you imagine the up take ???? I give up !!!
The opinion of the World Economic Forum is valuable, more than likely DSM PR have been keeping them informed of progress. On its own it doesnt sell shares in Provexis, new brands of the right type and/or confirmation of revenue flows after increased production investment is absorbed is what we need. Nevertheless, the view of a respected world body does validate the view of investors here. The bigger launches will come, during this year IMHO, and the sp will respond accordingly. Fruitflow has come a long long way since ADR discovered it.
Be adaptable to the needs of the partner and develop on-going mutual benefits
DSM/Provexis: DSM and Provexis jointly made Fruitflow® a commercial success – a natural tomato extract that prevents blood platelet from hyper-aggregation and helps to maintain a healthy blood flow. DSM invested to acquire a minority share through its venturing arm and agreed with Provexis on a global exclusive license agreement for Fruitflow®: Provexis is maintaining Intellectual Property and contributes technical and scientific expertise, DSM avails skills, know-how, and network to take the product to customers on a global level – both parties participate in commercialization of the project through a profit sharing agreement.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.